On 1/12/24, T2 Biosystems Inc (NASDAQ: TTOO) stock suffered a major decline of -11.1%, closing at $4.16. However, this decline was accompanied by exceptionally low trading volume at 46% of normal. Relative to the market the stock has been extremely weak over the last nine months and has declined -24.4% during the last week.
Current PriceTarget Research Rating
TTOO's future returns on capital are forecasted to be below the cost of capital. Accordingly, the company is expected to continue to be a major Value Eraser.
T2 Biosystems is currently unrated.
Rating Review
The stock is currently unrated.